Clearstead Trust’s Dynavax Technologies DVAX Stock Holding History

Clearstead Trust’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-85	Closed	-$845	–	1157
2025 Q3	$845	Hold	85	–	–	﹤0.01%	1262
2025 Q2	$844	Buy	+85	New	+$896	﹤0.01%	1212

Other funds holding DVAX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Clearstead Trust's DVAX Position: Q4 2025 in Review

Clearstead Trust sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 85 shares — an estimated $845 sold.

Clearstead Trust first reported a position in DVAX in Q2 2025 and held it in 2 quarters. The position peaked at $845 in Q3 2025. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

Clearstead Trust reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
Clearstead Trust sold 85 Dynavax Technologies shares in Q4 2025, an estimated $845.
Clearstead Trust first reported a position in Dynavax Technologies in Q2 2025 and held it in 2 quarters.
Clearstead Trust's Dynavax Technologies position peaked at $845 in Q3 2025.
266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Clearstead Trust's 13F filing for Q4 2025, filed 9 Feb 2026.